in black and white
Main menu
Share a book About us Home
Biology Business Chemistry Computers Culture Economics Fiction Games Guide History Management Mathematical Medicine Mental Fitnes Physics Psychology Scince Sport Technics

Principles and practice of Clinical parasitology - Gillespie S.

Gillespie S. Principles and practice of Clinical parasitology - Wiley publishing , 2001. - 675 p.
ISBN 0-471-97729-2
Download (direct link): principlesandpracticeofclin2001.pdf
Previous << 1 .. 76 77 78 79 80 81 < 82 > 83 84 85 86 87 88 .. 212 >> Next

Palmer KJ, Holliday SM, Brogden RN (1993). Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45: 430-75.
Pasvol G, Newton CRJC, Winstanley PA et al. (1991). Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimes. Am J Trop Med Hyg 45: 702-13.
Pasvol G., Weatherall DJ, Wilson RJM (1977). Effects of fetal hemoglobin on susceptibility of red cells to P. falciparum. Nature 270: 171-3.
Patarroyo ME, Romero P, Torres ML et al. (1987). Inductive of protective immunity against experimental infection with malaria using synthetic peptides. Nature 328: 629-32.
Phillips EJ, Keystone JS, Kain KC (1996). Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America [see comments]. Clin Infect Dis 23: 1171-3.
Phillips-Howard PA, Radalowicz A, Mitchell J et al. (1990). Risk of malaria in British residents returning from malarious areas. Br Med J 300: 499-503.
Phillips-Howard PA, Steffen R, Kerr L et al. (1998). Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 5: 121-6.
Phillips-Howard PA, ter Kuile, FO (1995). CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Safety 12: 370-83.
Phillips-Howard PA, Wood D (1996). The safety of antimalarial drugs in pregnancy. Drug Safety 14: 131-45.
Piessens WF, Hoffman SL, Wadee AA et al. (1985). Antibody-mediated killing of suppressor T lymphocytes as a possible cause of macroglobulinaemia in the tropical splenomegaly syndrome. J Clin Invest 75: 1821-7.
Price R, Nosten F, Luxemburger C et al. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet ii: 701-7.
Radloff PD, Philipps J, Nkeyi M et al. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-14.
Ree GH, Sargeaunt PG (1976). Laboratory diagnosis of malaria. Br Med J 1: 152.
Reeder JC, Cowman AF, Davern KM et al. (1999). The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1. Proc Natl AcadSci USA 96: 5198-202.
Rieckmann KH, Davis DR, Hutton DC (1989). Plasmodium vivax resistance to chloroquine? Lancet 2: 1183-4.
Rieckmann KH, Yeo AET, Davis DR et al. (1993). Recent military experience with malaria chemoprophylxis. Med J Aust 158: 446-9.
Rogers MJ, Li J, McCutchan TF (1998). Developmental regulation and drug target. In Sherman IW (ed.), Malaria. Parasite Biology, Pathogenesis, and Protection. ASM Press: Washington, DC; 203-18.
Rogers WO, Hoffman SL (1999). Malaria Vaccines. In: Malaria. Molecular and Clinical Aspects. Eds M Wahlgren, P Perlmann. Harwood Academic Publishers, pp. 439-94.
Rogerson SJ, Brown GV (1997). Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum infected erythrocytes. Parasitol Today 13: 70-5.
Rogerson SJ, Chaiyaroj S, Ng K et al. (1995). Chondroitin sulphate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 182: 15-20.
Ross R (1897). On some peculiar pigmented cells found in two mosquitos fed on malarial blood. Br Med J 2: 1786-8.
Rowe A, Obeiro J, Newbold CI et al. (1995). Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-6.
Ruwende C, Khoo SC, Snow RW et al. (1995). Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-9.
Samuel BU, Barry M (1998). The pregnant traveller. Infect Dis Clin North Am 12: 325-68.
Schapira A, Fogh S, Jepsen S et al. (1984). Detection of antibodies to malaria: comparison of results with ELISA, IFAT, and crossed immunoelectrophoresis. Acta Pathol Microbiol Immunol Scand B 92: 299-304.
Schlagenhauf P, Steffen R, Tschopp A et al. (1995). Behavioural aspects of travellers in their use of malarial presumptive treatment. Bull WHO 73: 215-21.
Schofield L, Vivas L, Hackett F et al. (1993). Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNFa-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. Ann Trop Med Parasitol 87: 617-26.
Schultz LJ, Steketee RW, Macheso A et al. (1994). The efficacy of antimalarial regimens containing sulphadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-22.
Shanks GD, Gordon DM, Klotz FW et al. (1998). Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 27: 494-9.
Shiff CJ, Minjas J, Premji Z (1993). The rapid manual Parasight-F test. A new diagnostic tool for Plasmodium falciparum infection. Trans R Soc Trop Med Hyg 87: 43643.
Sholapurkar S, Gupta A, Mahajan R (1988). Clinical course of malaria in pregnancy: A prospective controlled study from India. Trans R Soc Trop Med Hyg 82: 376-9.
Previous << 1 .. 76 77 78 79 80 81 < 82 > 83 84 85 86 87 88 .. 212 >> Next